SENTI BIOSCIENCES INC (SNTI) Fundamental Analysis & Valuation

NASDAQ:SNTI • US81726A2096

Current stock price

0.93 USD
+0.03 (+3.33%)
Last:

This SNTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SNTI Profitability Analysis

1.1 Basic Checks

  • SNTI had negative earnings in the past year.
  • SNTI had a negative operating cash flow in the past year.
  • In the past 5 years SNTI always reported negative net income.
  • SNTI had a negative operating cash flow in each of the past 5 years.
SNTI Yearly Net Income VS EBIT VS OCF VS FCFSNTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • SNTI has a worse Return On Assets (-119.94%) than 80.23% of its industry peers.
  • With a Return On Equity value of -1099.27%, SNTI is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -119.94%
ROE -1099.27%
ROIC N/A
ROA(3y)-77.79%
ROA(5y)-64.55%
ROE(3y)-436.49%
ROE(5y)-289.37%
ROIC(3y)N/A
ROIC(5y)N/A
SNTI Yearly ROA, ROE, ROICSNTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • SNTI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNTI Yearly Profit, Operating, Gross MarginsSNTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 -50K -100K -150K -200K -250K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SNTI Health Analysis

2.1 Basic Checks

  • SNTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SNTI has more shares outstanding
  • SNTI has more shares outstanding than it did 5 years ago.
  • SNTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SNTI Yearly Shares OutstandingSNTI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
SNTI Yearly Total Debt VS Total AssetsSNTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • SNTI has an Altman-Z score of -13.32. This is a bad value and indicates that SNTI is not financially healthy and even has some risk of bankruptcy.
  • SNTI has a worse Altman-Z score (-13.32) than 78.49% of its industry peers.
  • There is no outstanding debt for SNTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.32
ROIC/WACCN/A
WACC9.15%
SNTI Yearly LT Debt VS Equity VS FCFSNTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that SNTI should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.67, SNTI is not doing good in the industry: 80.23% of the companies in the same industry are doing better.
  • SNTI has a Quick Ratio of 1.67. This is a normal value and indicates that SNTI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.67, SNTI is not doing good in the industry: 79.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
SNTI Yearly Current Assets VS Current LiabilitesSNTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SNTI Growth Analysis

3.1 Past

  • SNTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.38%, which is quite impressive.
  • The Revenue for SNTI have been decreasing by -47.77% on average. This is quite bad
EPS 1Y (TTM)72.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.9%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-82.75%
Revenue growth 5Y-47.77%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 13.88% on average over the next years. This is quite good.
  • Based on estimates for the next years, SNTI will show a very strong growth in Revenue. The Revenue will grow by 196.56% on average per year.
EPS Next Y58.66%
EPS Next 2Y28.9%
EPS Next 3Y15.83%
EPS Next 5Y13.88%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y148.66%
Revenue Next 5Y196.56%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNTI Yearly Revenue VS EstimatesSNTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2028 2029 2030 2031 2032 2033 100M 200M 300M
SNTI Yearly EPS VS EstimatesSNTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. SNTI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNTI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNTI Price Earnings VS Forward Price EarningsSNTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNTI Per share dataSNTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNTI's earnings are expected to grow with 15.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.9%
EPS Next 3Y15.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNTI Dividend Analysis

5.1 Amount

  • SNTI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNTI Fundamentals: All Metrics, Ratios and Statistics

SENTI BIOSCIENCES INC

NASDAQ:SNTI (4/14/2026, 10:25:36 AM)

0.93

+0.03 (+3.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-27
Earnings (Next)05-06
Inst Owners18.45%
Inst Owner Change0%
Ins Owners0.4%
Ins Owner Change-0.02%
Market Cap28.96M
Revenue(TTM)22.00K
Net Income(TTM)-61.44M
Analysts84
Price Target11.22 (1106.45%)
Short Float %4.51%
Short Ratio5.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.67%
Min EPS beat(2)-25.97%
Max EPS beat(2)-19.38%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-98.38%
Min Revenue beat(2)-100%
Max Revenue beat(2)-96.76%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.35%
PT rev (3m)-4.35%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)22.32%
EPS NY rev (3m)22.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1316.37
P/FCF N/A
P/OCF N/A
P/B 5.18
P/tB 5.18
EV/EBITDA N/A
EPS(TTM)-3.19
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.94%
ROE -1099.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.79%
ROA(5y)-64.55%
ROE(3y)-436.49%
ROE(5y)-289.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.39%
Cap/Sales 890.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z -13.32
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)114.71%
Cap/Depr(5y)804.89%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.9%
EPS Next Y58.66%
EPS Next 2Y28.9%
EPS Next 3Y15.83%
EPS Next 5Y13.88%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-82.75%
Revenue growth 5Y-47.77%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y148.66%
Revenue Next 5Y196.56%
EBIT growth 1Y-4.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.94%
OCF growth 3YN/A
OCF growth 5YN/A

SENTI BIOSCIENCES INC / SNTI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SENTI BIOSCIENCES INC (SNTI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SNTI.


What is the valuation status for SNTI stock?

ChartMill assigns a valuation rating of 0 / 10 to SENTI BIOSCIENCES INC (SNTI). This can be considered as Overvalued.


What is the profitability of SNTI stock?

SENTI BIOSCIENCES INC (SNTI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for SNTI stock?

The Earnings per Share (EPS) of SENTI BIOSCIENCES INC (SNTI) is expected to grow by 58.66% in the next year.